Company Filing History:
Years Active: 2018-2025
Title: Gary Ostrander: Innovator in Niclosamide Formulations
Introduction
Gary Ostrander is a prominent inventor based in Tallahassee, Florida. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on niclosamide compounds. With a total of nine patents to his name, Ostrander's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Gary Ostrander's latest patents involves niclosamide formulations and methods of use. This invention concerns compositions that include at least one niclosamide compound, such as niclosamide or a pharmaceutically acceptable salt thereof, along with a permeability enhancer like glycerol or dimethylpalmityl-ammonio propanesulfonate (PPS). The innovative aspect of this formulation is that the niclosamide compound can be transported across a Caco-2 cell membrane by at least 150% more than without the permeability enhancer. This advancement is particularly relevant for the treatment or prevention of human coronavirus infections, showcasing the potential of his work in addressing urgent health challenges.
Career Highlights
Gary Ostrander is affiliated with the Florida State University Research Foundation, Inc. His career has been marked by a commitment to research and innovation in the pharmaceutical field. His contributions have not only advanced scientific knowledge but also provided practical solutions for medical applications.
Collaborations
Ostrander has worked alongside notable colleagues such as Eric Holmes and Geoffrey Stuart Dow. These collaborations have likely enriched his research and contributed to the success of his innovative projects.
Conclusion
In summary, Gary Ostrander is a distinguished inventor whose work in niclosamide formulations holds promise for significant medical advancements. His dedication to research and collaboration continues to drive innovation in the pharmaceutical industry.